INFECTIONS IN NEUTROPENIC PATIENTS

Multidrug-resistant pathogens such as enterococci, coliforms and pseud omonads are becoming endemic in many units caring for neutropenic pati ents, probably because of the extensive use of prophylaxis and broad-s pectrum therapy. Further studies of febrile episodes in neutropenia in dicate that preventive and therapeutic regimens, such as quinolone pro phylaxis and empirical monotherapy, can safely be tailored for specifi c risk groups to a greater extent than before. The past year has seen an increasing emphasis in the literature on cost control in the treatm ent of neutropenic patients.